Angeliki’s research leverages the recently developed organ-on-chip microfluidics technology to simulate and study human diseases, including gastrointestinal disorders, inflammatory diseases, and cancer, with the ultimate goal of discovering novel therapeutics. Prior to joining the Wyss Institute, Angeliki worked as a Research Scientist at MIT, where her work focused on metabolic and age-related diseases, including obesity, diabetes, sarcopenia and muscle degeneration, using mouse models and cell-based systems. She has extensive experience in molecular and cellular biology, metabolism, and physiology, which she applies to create organs-on-chips that mimic human physiology and pathophysiology. Angeliki received her B.S. in Biology and her Ph.D. in Molecular Biology and Biomedicine from the University of Crete, followed by postdoctoral work at MIT.